C. Yenilmez Et Al. , "A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.42, no.1, pp.103-107, 2017
Yenilmez, C. Et Al. 2017. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.42, no.1 , 103-107.
Yenilmez, C., Koroglu, Z. O., KURT, H., Yanas, M., Colak, E., DEĞİRMENCİ, İ., ... Gunes, H. V.(2017). A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.42, no.1, 103-107.
Yenilmez, C. Et Al. "A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.42, no.1, 103-107, 2017
Yenilmez, C. Et Al. "A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.42, no.1, pp.103-107, 2017
Yenilmez, C. Et Al. (2017) . "A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.42, no.1, pp.103-107.
@article{article, author={C. Yenilmez Et Al. }, title={A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes}, journal={JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS}, year=2017, pages={103-107} }